Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas ; volume:7 ; number:1 ; day:22 ; month:6 ; year:2007 ; pages:1-7 ; date:12.2007
BMC cancer ; 7, Heft 1 (22.6.2007), 1-7, 12.2007
- Creator
-
Levin, Victor A.
- Contributor
-
Ictech, Sandra
Hess, Kenneth R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-7-106
- URN
-
urn:nbn:de:1111-2016030342694
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Levin, Victor A.
- Ictech, Sandra
- Hess, Kenneth R.
- SpringerLink (Online service)
Other Objects (12)
Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival
Progression-free or overall survival…revisited in BOLERO-2
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Potential prognostic factors in progression-free survival for patients with cervical cancer
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
Time-dependent endpoints as predictors of overall survival in multiple myeloma
Design of Phase II cancer trials evaluating survival probabilities
Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival
Progression-free or overall survival…revisited in BOLERO-2
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Potential prognostic factors in progression-free survival for patients with cervical cancer
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
Time-dependent endpoints as predictors of overall survival in multiple myeloma
Design of Phase II cancer trials evaluating survival probabilities
Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival
Progression-free or overall survival…revisited in BOLERO-2
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Potential prognostic factors in progression-free survival for patients with cervical cancer
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
Time-dependent endpoints as predictors of overall survival in multiple myeloma